These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32074682)

  • 1. [Return of non-fluorinated quinolones: a novel landmark in the developing history of quinolone antimicrobial agents].
    He LX
    Zhonghua Nei Ke Za Zhi; 2020 Feb; 59(2):99-103. PubMed ID: 32074682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story".
    Bisacchi GS
    J Med Chem; 2015 Jun; 58(12):4874-82. PubMed ID: 25738967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quinolones: past, present, and future.
    Andriole VT
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S113-9. PubMed ID: 15942877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evolution of quinolone: from nalidixic acid to the quinolones of the third generation].
    Petersen U
    Pharm Unserer Zeit; 2001; 30(5):376-81. PubMed ID: 11575173
    [No Abstract]   [Full Text] [Related]  

  • 6. Paul Ehrlich, a prescient pioneer in the field of antimicrobial chemotherapy: what did he foresee a century ago?
    Tillotson GS; Zinner SH
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):113-5. PubMed ID: 23409816
    [No Abstract]   [Full Text] [Related]  

  • 7. A Brief History of Antimicrobial Resistance.
    Hunt D; Kates OS
    AMA J Ethics; 2024 May; 26(5):E408-417. PubMed ID: 38700525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone.
    Li CR; Li Y; Li GQ; Yang XY; Zhang WX; Lou RH; Liu JF; Yuan M; Huang P; Cen S; Yu LY; Zhao LX; Jiang JD; You XF
    J Antimicrob Chemother; 2010 Nov; 65(11):2411-5. PubMed ID: 20858687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-antibiotics--drugs with additional antimicrobial activity.
    Tyski S
    Acta Pol Pharm; 2003; 60(5):401-4. PubMed ID: 15005425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
    Weller TM; Andrews JM; Jevons G; Wise R
    J Antimicrob Chemother; 2002 Jan; 49(1):177-84. PubMed ID: 11751785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic therapy over half a century: a tale of discovery from chlorpromazine to aripiprazole.
    Natesan S; Kapur S
    Natl Med J India; 2012; 25(4):193-5. PubMed ID: 23278774
    [No Abstract]   [Full Text] [Related]  

  • 12. Make Antibiotics Great Again.
    Ashar BH
    Med Clin North Am; 2018 Sep; 102(5):xix-xx. PubMed ID: 30126586
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
    Kocsis B; Domokos J; Szabo D
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics: from prehistory to the present day.
    Gould K
    J Antimicrob Chemother; 2016 Mar; 71(3):572-5. PubMed ID: 26851273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment and susceptibility testing.
    Kerr JR
    J Clin Pathol; 2005 Aug; 58(8):786-7. PubMed ID: 16049274
    [No Abstract]   [Full Text] [Related]  

  • 16. Silver in medicine: a brief history BC 335 to present.
    Barillo DJ; Marx DE
    Burns; 2014 Dec; 40 Suppl 1():S3-8. PubMed ID: 25418435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The birth of the antibiotic era.
    Ellis H
    Br J Hosp Med (Lond); 2016 Aug; 77(8):485. PubMed ID: 27487061
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in bacteria: history, genetics and biochemistry.
    Mitsuhashi S
    J Int Med Res; 1993; 21(1):1-14. PubMed ID: 8319816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial resistance forever? Judicious and appropriate use of antibiotics].
    Cagliano S
    Recenti Prog Med; 2015 Jun; 106(6):283-4. PubMed ID: 26076416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.